232
1. Brodeur GM, Bagatell R. Mechanisms of neuroblastoma tumorigenesis. Nat Rev Cancer. 2014;14(12):771-784. doi:10.1038/nrc3844.
2. Cohn SL, Pearson ADJ, London WB, et al. The International Neuroblastoma Risk Group (INRG) classification system: An INRG Task Force report. J Clin Oncol. 2009;27(2):289-297. doi:10.1200/JCO.2008.16.6785.
3. Erbey F, Karadeniz C, Yılmaz S, ve ark. TPOG Nöroblastom Tanı ve Tedavi Protokolü (TPOG-NB-2020). Türk Pediatrik Onkoloji Grubu; 2020. Erişim: 02.12.2024.
4. Hernandez Tejada FN, Harrison DJ. Neuroblastoma. In: Kliegman RM, St Geme JW, Blum NJ, Shah SS, Tasker RC, Wilson KM, eds. Nelson Textbook of Pediatrics. 22nd ed. Philadelphia, PA: Elsevier; 2024:3125-3130.
5. Hero B, Simon T. IDRF-based surgical decision-making in neuroblastoma. Cancer Lett. 2020;476:48-54. doi:10.1016/j.canlet.2020.03.017.
6. London WB, Bagatell R, Cohn SL, et al. Historical and current perspectives on neuroblastoma risk classification. Pediatr Blood Cancer. 2021;68(11):e29040. doi:10.1002/pbc.29040.
7. Maris JM. Recent advances in neuroblastoma. N Engl J Med. 2010;362(23):2202-2211. doi:10.1056/NEJMra0804577.
8. Matthay KK, Maris JM, Schleiermacher G, et al. Neuroblastoma. Nat Rev Dis Primers. 2016;2:16078. doi:10.1038/nrdp.2016.78.
9. Nuchtern JG. Perinatal and infant neuroblastoma. Semin Pediatr Surg. 2006;15(1):10-21. doi:10.1053/j.sempedsurg.2005.11.003.
10. Pizzo PA, Poplack DG, eds. Neuroblastoma. In: Lanzkowsky P, Lipton JM, Fish JD, eds. Lanzkowsky’s Manual of Pediatric Hematology and Oncology. 7th ed. Amsterdam: Elsevier; 2021:507-523.
11. Sallan SE, Grovas AC. Neuroblastoma. In: Orkin SH, Fisher DE, Look AT, Lux SE, Ginsburg D, Nathan DG, Oski FA, eds. Nathan and Oski’s Hematology and Oncology of Infancy and Childhood. 8th ed. Philadelphia, PA: Elsevier; 2015:1675-1713.
12. Simon T, Häberle B, Hero B, von Schweinitz D, Berthold F. Role of surgery in the treatment of patients with stage 4 neuroblastoma age ≥18 months at diagnosis. J Clin Oncol. 2013;31(6):752-758. doi:10.1200/JCO.2012.45.9337.